Research support for AI-ML project
Ended Awarded Last action
- Contract number
- 75F40123F19311
- Awardee
-
Brillient Corporation UEI MMAVC7UGLJ78
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $166,315
Award facts
- Contract value 100% obligated
- $166,314.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Reston, VA 20190, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$13,380 | |
| Other Administrative Action | $0 | |
| Original award | $179,695 |
About this award
This is a federal contract award from the Food and Drug Administration (FDA), a civilian agency, to Brillient Corporation, a minority-owned, for-profit Subchapter S Corporation. The contract, valued at $166,314.77, is a Blanket Purchase Agreement (BPA) call under the General Services Administration's (GSA) Multiple Award Schedule (MAS) contract vehicle for professional and technical services. The contract is for research support for an artificial intelligence and machine learning (AI-ML) project, with a period of performance through August 24, 2024. Brillient Corporation is an experienced federal contractor, having been awarded numerous contracts from agencies such as the Department of Health and Human Services, Department of Homeland Security, and National Institutes of Health, covering a range of professional and technical services. This contract award does not have a set-aside designation.
Quick answers
Who was awarded contract 75F40123F19311?
75F40123F19311 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on August 25, 2023.
How much is contract 75F40123F19311 worth?
The government has obligated $166,315 on 75F40123F19311.
Is contract 75F40123F19311 an order under another contract?
Yes. 75F40123F19311 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40123F19311 competed?
The extent of competition for 75F40123F19311 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award